Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24323034 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Conditions: Cancer;   Prostate Neoplasms
Interventions: Drug: goserelin with dutasteride;   Drug: goserelin with bicalutamide and dutasteride;   Drug: goserelin with bicalutamide and dutasteride and ketoconazole

Indicates status has not been verified in more than two years